Eli Lilly and Co., of Indianapolis, requested the delisting of its shares from Euronext Paris due to the very low trading volume, costs and administrative requirements related to its secondary listing on Euronext Paris. The board of the exchange has approved the request. Lilly's shares will remain listed on the New York Stock Exchange.